MERRILL S KIES

TitleProfessor
InstitutionMD Anderson
DepartmentThoracic Head & Neck Medical Oncology
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gay CM, Zhou Y, Lee JJ, Tang XM, Lu W, Wistuba II, Ferrarotto R, Gibbons DL, Glisson BS, Kies MS, Simon GR, Heymach JV, Tsao AS. A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma. Oncologist. 2020 Jul 01. PMID: 32608142.
      Citations:    Fields:    
    2. Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY. Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2019 Aug 01; 25(15):4861. PMID: 31371311.
      Citations:    Fields:    
    3. Haddad RI, Massarelli E, Lee JJ, Lin HY, Hutcheson K, Lewis J, Garden AS, Blumenschein GR, William WN, Pharaon RR, Tishler RB, Glisson BS, Pickering C, Gold KA, Johnson FM, Rabinowits G, Ginsberg LE, Williams MD, Myers J, Kies MS, Papadimitrakopoulou V. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Ann Oncol. 2019 03 01; 30(3):471-477. PMID: 30596812.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    4. Massarelli E, William W, Johnson F, Kies M, Ferrarotto R, Guo M, Feng L, Lee JJ, Tran H, Kim YU, Haymaker C, Bernatchez C, Curran M, Zecchini Barrese T, Rodriguez Canales J, Wistuba I, Li L, Wang J, van der Burg SH, Melief CJ, Glisson B. Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. JAMA Oncol. 2019 01 01; 5(1):67-73. PMID: 30267032.
      Citations: 36     Fields:    Translation:HumansCellsCTClinical Trials
    5. Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, Kies MS, Maity SN, Lin SH, El-Naggar AK. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 2018 09 15; 124(18):3693-3705. PMID: 30289966.
      Citations: 6     Fields:    Translation:HumansCells
    6. Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113. PMID: 29735186.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    7. Gold KA, Kies MS, William WN, Johnson FM, Lee JJ, Glisson BS. Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial. Cancer. 2018 05 15; 124(10):2169-2173. PMID: 29579331.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    8. Ferrarotto R, Cardnell R, Su S, Diao L, Eterovic AK, Prieto V, Morrisson WH, Wang J, Kies MS, Glisson BS, Byers LA, Bell D. Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma. Head Neck. 2018 08; 40(8):1676-1684. PMID: 29570891.
      Citations: 1     Fields:    Translation:HumansCells
    9. William WN, Tsao AS, Feng L, Ginsberg LE, Lee JJ, Kies MS, Glisson BS, Kim ES. Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas. Oncologist. 2018 05; 23(5):526-e49. PMID: 29371473.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    10. William WN, Feng L, Ferrarotto R, Ginsberg L, Kies M, Lippman S, Glisson B, Kim ES. Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial. J Am Acad Dermatol. 2017 Dec; 77(6):1110-1113.e2. PMID: 28964539.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    11. Tsimberidou AM, Hong DS, Ye Y, Cartwright C, Wheler JJ, Falchook GS, Naing A, Fu S, Piha-Paul S, Janku F, Meric-Bernstam F, Hwu P, Kee B, Kies MS, Broaddus R, Mendelsohn J, Hess KR, Kurzrock R. Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study. JCO Precis Oncol. 2017; 2017. PMID: 29082359.
      Citations:    
    12. Pollard C, Mesko SM, Ginsberg LE, Kies MS, Raza SM, Su SY, Tung S, Phan J. Nasopharyngeal carcinoma presenting as an inconspicuous primary lesion with extensive cavernous sinus involvement and temporal lobe extension: a case report and review of literature. Clin Case Rep. 2017 10; 5(10):1682-1688. PMID: 29026572.
      Citations:    
    13. Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, Frank SJ, Fuller CD, Gunn GB, Kies MS, Glisson BS, Hanna EY. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017 08; 39(8):1671-1679. PMID: 28561956.
      Citations: 7     Fields:    Translation:Humans
    14. Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck. 2017 08; 39(8):1609-1620. PMID: 28464542.
      Citations: 2     Fields:    Translation:Humans
    15. Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck. 2017 08; 39(8):1516-1523. PMID: 28452175.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    16. McKeever MR, Sio TT, Gunn GB, Holliday EB, Blanchard P, Kies MS, Weber RS, Frank SJ. Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. Chin Clin Oncol. 2016 Aug; 5(4):54. PMID: 27506808.
      Citations: 1     Fields:    Translation:Humans
    17. Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751. PMID: 27466789.
      Citations: 5     Fields:    Translation:Humans
    18. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope. 2017 04; 127(4):842-848. PMID: 27440393.
      Citations: 3     Fields:    Translation:Humans
    19. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer. 2016 11 15; 122(21):3411-3412. PMID: 27420634.
      Citations: 1     Fields:    Translation:HumansCells
    20. Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol. 2016 07; 120(1):48-55. PMID: 27342249.
      Citations: 21     Fields:    Translation:Humans
    21. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):700-708. PMID: 27485284.
      Citations: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    22. Liu X, Kambrick S, Fu S, Naing A, Subbiah V, Blumenschein GR, Glisson BS, Kies MS, Tsimberidou AM, Wheler JJ, Zinner RG, Hong DS, Kurzrock R, Piha-Paul SA. Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus. Oncotarget. 2016 Apr 26; 7(17):23227-38. PMID: 26933802.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    23. Esmaeli B, Yin VT, Hanna EY, Kies MS, William WN, Bell D, Frank SJ. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma. Head Neck. 2016 08; 38(8):1258-62. PMID: 27027275.
      Citations: 4     Fields:    Translation:Humans
    24. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer. 2016 06 01; 122(11):1702-7. PMID: 27019396.
      Citations: 1     Fields:    Translation:HumansCells
    25. Holliday E, Bhattasali O, Kies MS, Hanna E, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Phan J, Zhu XR, Zhang X, Frank SJ. Postoperative Intensity-Modulated Proton Therapy for Head and Neck Adenoid Cystic Carcinoma. Int J Part Ther. 2016 Mar; 2(4):533-543. PMID: 31772965.
      Citations:    
    26. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1117-31. PMID: 27354127.
      Citations: 14     Fields:    Translation:Humans
    27. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367. PMID: 27084653.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    28. Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS. Depression and Oropharynx Cancer Outcome. Psychosom Med. 2016 Jan; 78(1):38-48. PMID: 26632757.
      Citations: 5     Fields:    Translation:HumansCells
    29. Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res. 2016 Feb 01; 22(3):725-33. PMID: 26631609.
      Citations: 39     Fields:    Translation:HumansCells
    30. Nien HH, Sturgis EM, Kies MS, El-Naggar AK, Morrison WH, Beadle BM, Johnson FM, Gunn GB, Fuller CD, Phan J, Gold KA, Frank SJ, Skinner H, Rosenthal DI, Garden AS. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck. 2016 04; 38 Suppl 1:E1554-61. PMID: 26595157.
      Citations: 3     Fields:    Translation:HumansCells
    31. Wong SJ, Karrison T, Hayes DN, Kies MS, Cullen KJ, Tanvetyanon T, Argiris A, Takebe N, Lim D, Saba NF, Worden FP, Gilbert J, Lenz HJ, Razak AR, Roberts JD, Vokes EE, Cohen EE. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol. 2016 Feb; 27(2):318-23. PMID: 26598548.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    32. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck. 2016 04; 38 Suppl 1:E1472-80. PMID: 26561041.
      Citations: 3     Fields:    Translation:Humans
    33. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer. 2016 Mar 01; 138(5):1290-7. PMID: 26414107.
      Citations: 5     Fields:    Translation:Humans
    34. Holliday EB, Esmaeli B, Pinckard J, Garden AS, Rosenthal DI, Morrison WH, Kies MS, Gunn GB, Fuller CD, Phan J, Beadle BM, Zhu XR, Zhang X, Frank SJ. A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):344-352. PMID: 26454680.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    35. Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH. Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. Head Neck. 2016 04; 38 Suppl 1:E452-8. PMID: 25645649.
      Citations: 3     Fields:    Translation:Humans
    36. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-55; quiz 856. PMID: 26150579.
      Citations: 44     Fields:    Translation:Humans
    37. Massarelli E, Lin H, Ginsberg LE, Tran HT, Lee JJ, Canales JR, Williams MD, Blumenschein GR, Lu C, Heymach JV, Kies MS, Papadimitrakopoulou V. Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol. 2015 Jul; 26(7):1476-80. PMID: 26025965.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    38. Ozgur OK, Yin V, Chou E, Ball S, Kies M, William WN, Migden M, Thuro BA, Esmaeli B. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome. Am J Ophthalmol. 2015 Aug; 160(2):220-227.e2. PMID: 25935097.
      Citations: 6     Fields:    Translation:Humans
    39. Jakob JA, Kies MS, Glisson BS, Kupferman ME, Liu DD, Lee JJ, El-Naggar AK, Gonzalez-Angulo AM, Blumenschein GR. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck. 2015 May; 37(5):644-9. PMID: 24585506.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    40. Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, El-Naggar A, Perrone F, Licitra L, Bossi P, Kimmel M, Frederick MJ, Lichtarge O, Myers JN. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Res. 2015 Apr 01; 75(7):1205-15. PMID: 25691460.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    41. Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, Beadle BM, El-Naggar AK, Kies MS, William WN, Caulin C, Frederick M, Kimmel M, Myers JN, Lichtarge O. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Res. 2015 Apr 01; 75(7):1527-36. PMID: 25634208.
      Citations: 44     Fields:    Translation:HumansCells
    42. Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, Morrison WH, Lewin JS, El-Naggar AK, Ginsberg LE, Kocak-Uzel E, Ang KK, Fuller CD. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Cancer. 2015 May 15; 121(10):1608-19. PMID: 25586197.
      Citations: 25     Fields:    Translation:Humans
    43. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81. PMID: 25316813.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    44. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87. PMID: 25313184.
      Citations: 54     Fields:    Translation:Humans
    45. Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang K. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol. 2014 Aug 10; 32(23):2486-95. PMID: 25002723.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    46. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer. 2014 Oct 01; 120(19):3082-8. PMID: 24898672.
      Citations: 6     Fields:    Translation:HumansCells
    47. Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):846-53. PMID: 24867532.
      Citations: 22     Fields:    Translation:Humans
    48. Neskey DM, Klein JD, Hicks S, Garden AS, Bell DM, El-Naggar AK, Kies MS, Weber RS, Kupferman ME. Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1195-202. PMID: 24076756.
      Citations: 3     Fields:    Translation:Humans
    49. Blumenschein GR, Saintigny P, Liu S, Kim ES, Tsao AS, Herbst RS, Alden C, Lee JJ, Tang X, Stewart DJ, Kies MS, Fossella FV, Tran HT, Mao L, Hicks ME, Erasmus J, Gupta S, Girard L, Peyton M, Diao L, Wang J, Davis SE, Minna JD, Wistuba I, Hong WK, Heymach JV, Lippman SM. Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial. Clin Cancer Res. 2013 Dec 15; 19(24):6967-75. PMID: 24166906.
      Citations: 19     Fields:    Translation:Humans
    50. Ganesan P, Piha-Paul S, Naing A, Falchook G, Wheler J, Janku F, Zinner R, Laday S, Kies M, Tsimberidou AM. Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer. Invest New Drugs. 2013 Dec; 31(6):1505-13. PMID: 23982248.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    51. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Aug; 11(8):917-23. PMID: 23946171.
      Citations: 48     Fields:    Translation:Humans
    52. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, El-Naggar AK. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778. PMID: 23825564.
      Citations: 14     Fields:    Translation:HumansCells
    53. Hutcheson KA, Lewin JS, Holsinger FC, Steinhaus G, Lisec A, Barringer DA, Lin HY, Villalobos S, Garden AS, Papadimitrakopoulou V, Kies MS. Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck. 2014 Apr; 36(4):474-80. PMID: 23780650.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    54. Ganesan P, Piha-Paul S, Naing A, Falchook G, Wheler J, Fu S, Hong DS, Kurzrock R, Janku F, Laday S, Bedikian AY, Kies M, Wolff RA, Tsimberidou AM. Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer. Invest New Drugs. 2014 Apr; 32(2):279-86. PMID: 23756764.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    55. Perissinotti AJ, Lee Pierce M, Pace MB, El-Naggar A, Kies MS, Kupferman M. The role of trastuzumab in the management of salivary ductal carcinomas. Anticancer Res. 2013 Jun; 33(6):2587-91. PMID: 23749912.
      Citations: 8     Fields:    Translation:Humans
    56. Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman SM, El-Naggar AK. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57. PMID: 23583282.
      Citations: 7     Fields:    Translation:Humans
    57. Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, Gunn GB, Beadle BM, Ang KK, Rosenthal DI, Sturgis EM. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol. 2013 Jan 29; 8:21. PMID: 23360540.
      Citations: 29     Fields:    Translation:Humans
    58. El-Sawy T, Sabichi AL, Myers JN, Kies MS, William WN, Glisson BS, Lippman S, Esmaeli B. Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Arch Ophthalmol. 2012 Dec; 130(12):1608-11. PMID: 23229707.
      Citations: 3     Fields:    Translation:Humans
    59. Zhong LP, Zhang CP, Ren GX, Guo W, William WN, Sun J, Zhu HG, Tu WY, Li J, Cai YL, Wang LZ, Fan XD, Wang ZH, Hu YJ, Ji T, Yang WJ, Ye WM, Li J, He Y, Wang YA, Xu LQ, Wang BS, Kies MS, Lee JJ, Myers JN, Zhang ZY. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2013 Feb 20; 31(6):744-51. PMID: 23129742.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    60. Sandulache VC, Ow TJ, Daram SP, Hamilton J, Skinner H, Bell D, Rosenthal DI, Beadle BM, Ang KK, Kies MS, Johnson FM, El-Naggar AK, Myers JN. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck. 2013 Oct; 35(10):1454-60. PMID: 23018868.
      Citations: 2     Fields:    Translation:Humans
    61. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):941-7. PMID: 22975604.
      Citations: 34     Fields:    Translation:Humans
    62. Argiris A, Kotsakis AP, Hoang T, Worden FP, Savvides P, Gibson MK, Gyanchandani R, Blumenschein GR, Chen HX, Grandis JR, Harari PM, Kies MS, Kim S. Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol. 2013 Jan; 24(1):220-5. PMID: 22898037.
      Citations: 54     Fields:    Translation:HumansCTClinical Trials
    63. Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A, Weber RS, Wolf G, Worden F. Mucosal melanoma of the head and neck. J Natl Compr Canc Netw. 2012 Mar; 10(3):320-38. PMID: 22393194.
      Citations: 6     Fields:    Translation:Humans
    64. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, Weber RS, Kupferman ME. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012 Aug 15; 118(16):3928-36. PMID: 22180391.
      Citations: 28     Fields:    Translation:Humans
    65. Komaki R, Wei X, Allen PK, Liao Z, Milas L, Cox JD, O'Reilly MS, Chang JY, McAleer MF, Jeter M, Blumenschein GR, Kies MS. Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer. Front Oncol. 2011; 1:52. PMID: 22649768.
      Citations:    
    66. Tsao AS, Liu S, Fujimoto J, Wistuba II, Lee JJ, Marom EM, Charnsangavej C, Fossella FV, Tran HT, Blumenschein GR, Papadimitrakopoulou V, Kies MS, Hong WK, Stewart DJ. Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. J Thorac Oncol. 2011 Dec; 6(12):2104-11. PMID: 21892101.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    67. Samant S, van den Brekel MW, Kies MS, Wan J, Robbins KT, Rosenthal DI, Rasch C, Weber RS. Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck. Head Neck. 2012 Sep; 34(9):1263-8. PMID: 22083968.
      Citations: 9     Fields:    Translation:Humans
    68. Kies MS, Boatright DH, Li G, Blumenschein G, El-Naggar AK, Brandon Gunn G, Lewin JS, Steinhaus GD, Sturgis EM. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults. Head Neck. 2012 Sep; 34(9):1255-62. PMID: 22009800.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    69. Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, Stewart DJ, Hicks ME, Erasmus J, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman SM, Hong WK. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 2011 Jun; 1(1):44-53. PMID: 22586319.
      Citations: 269     Fields:    Translation:HumansCTClinical Trials
    70. Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A, Weber RS, Wolf GT, Worden F. Head and neck cancers. J Natl Compr Canc Netw. 2011 Jun 01; 9(6):596-650. PMID: 21636536.
      Citations: 54     Fields:    Translation:Humans
    71. Hanna EY, Cardenas AD, DeMonte F, Roberts D, Kupferman M, Weber R, Rosenthal D, Kies M. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81. PMID: 21242552.
      Citations: 12     Fields:    Translation:Humans
    72. Garden AS, Kies MS, Weber RS. To TORS or Not to TORS: but is that the question? Comment on "transoral robotic surgery for advanced oropharyngeal carcinoma". Arch Otolaryngol Head Neck Surg. 2010 Nov; 136(11):1085-7. PMID: 21079161.
      Citations: 2     Fields:    Translation:Humans
    73. Bell D, Roberts D, Kies M, Rao P, Weber RS, El-Naggar AK. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer. 2010 Dec 15; 116(24):5749-56. PMID: 20824717.
      Citations: 15     Fields:    Translation:Humans
    74. Schwartz DL, Hutcheson K, Barringer D, Tucker SL, Kies M, Holsinger FC, Ang KK, Morrison WH, Rosenthal DI, Garden AS, Dong L, Lewin JS. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1356-65. PMID: 20646872.
      Citations: 44     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    75. Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Wistuba II, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman SM, Heymach JV. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. . 2010 Jun; 9(6):1755-63. PMID: 20530716.
      Citations:    
    76. Garrido-Laguna I, Janku F, Falchook GS, Fu S, Hong DS, Naing A, Aaron J, Wang X, Kies M, Kurzrock R. Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment. Clin Cancer Res. 2010 Aug 01; 16(15):4031-7. PMID: 20525754.
      Citations: 5     Fields:    Translation:Humans
    77. William WN, Kies MS, Fossella FV, Liu DD, Gladish G, Tse WH, Lee JJ, Hong WK, Lippman SM, Kim ES. Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. Cancer. 2010 May 15; 116(10):2401-8. PMID: 20225327.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    78. Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res. 2010 Apr 15; 16(8):2266-74. PMID: 20371674.
      Citations: 40     Fields:    Translation:HumansCells
    79. Kies MS, Holsinger FC, Lee JJ, William WN, Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman SM, Hong WK, El-Naggar AK, Garden AS, Papadimitrakopoulou V. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 01; 28(1):8-14. PMID: 19917840.
      Citations: 55     Fields:    Translation:HumansCellsCTClinical Trials
    80. Hanrahan EO, Kies MS, Glisson BS, Khuri FR, Feng L, Tran HT, Ginsberg LE, Truong MT, Hong WK, Kim ES. A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2009 Jun; 32(3):274-9. PMID: 19433965.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    81. Barringer DA, Hutcheson KA, Sturgis EM, Kies MS, Lewin JS. Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer. Head Neck. 2009 May; 31(5):611-7. PMID: 19107949.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    82. Salama JK, Haddad RI, Kies MS, Busse PM, Dong L, Brizel DM, Eisbruch A, Tishler RB, Trotti AM, Garden AS. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):725-33. PMID: 19362781.
      Citations: 13     Fields:    Translation:Humans
    83. Holsinger FC, Kies MS, Diaz EM, Gillenwater AM, Lewin JS, Ginsberg LE, Glisson BS, Garden AS, Ark N, Lin HY, Lee JJ, El-Naggar AK, Ki Hong W, Shin DM, Khuri FR. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol. 2009 Apr 20; 27(12):1976-82. PMID: 19289628.
      Citations: 12     Fields:    Translation:Humans
    84. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest. 2008 Dec; 134(6):1349. PMID: 19059972.
      Citations:    Fields:    Translation:Humans
    85. Galer CE, Kies MS. Evaluation and management of the unknown primary carcinoma of the head and neck. J Natl Compr Canc Netw. 2008 Nov; 6(10):1068-75. PMID: 19176202.
      Citations:    Fields:    Translation:Humans
    86. Rapidis A, Sarlis N, Lefebvre JL, Kies M. Docetaxel in the treatment of squamous cell carcinoma of the head and neck. Ther Clin Risk Manag. 2008 Oct; 4(5):865-86. PMID: 19209269.
      Citations:    
    87. Figlin RA, Brown E, Armstrong AJ, Akerley W, Benson AB, Burstein HJ, Ettinger DS, Febbo PG, Fury MG, Hudes GR, Kies MS, Kwak EL, Morgan RJ, Mortimer J, Reckamp K, Venook AP, Worden F, Yen Y. NCCN Task Force Report: mTOR inhibition in solid tumors. J Natl Compr Canc Netw. 2008 Sep; 6 Suppl 5:S1-20; quiz S21-2. PMID: 18926092.
      Citations: 15     Fields:    Translation:HumansCells
    88. Forastiere AA, Ang KK, Brizel D, Brockstein BE, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Goepfert H, Hicks WL, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A, Weber RS, Wolf GT, Worden F. Head and neck cancers. J Natl Compr Canc Netw. 2008 Aug; 6(7):646-95. PMID: 18691457.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    89. Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):119-27. PMID: 18556142.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    90. Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Kies M, Glisson B, Weber R, Garden AS. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):399-409. PMID: 18556144.
      Citations: 42     Fields:    Translation:Humans
    91. Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol. 2008 Oct 10; 26(29):4708-13. PMID: 18541897.
      Citations: 197     Fields:    Translation:HumansCTClinical Trials
    92. Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessell AC, Lewin JS, Ang KK, Kies MS, Gning I, Wang XS, Cleeland CS. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61. PMID: 18501527.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    93. Rosenthal DI, Chambers MS, Fuller CD, Rebueno NC, Garcia J, Kies MS, Morrison WH, Ang KK, Garden AS. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):747-55. PMID: 18455324.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    94. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res. 2008 May 01; 14(9):2664-72. PMID: 18451230.
      Citations: 17     Fields:    Translation:HumansCells
    95. Holsinger FC, Kies MS, Weinstock YE, Lewin JS, Hajibashi S, Nolen DD, Weber R, Laccourreye O. Videos in clinical medicine. Examination of the larynx and pharynx. N Engl J Med. 2008 Jan 17; 358(3):e2. PMID: 18199857.
      Citations: 2     Fields:    Translation:Humans
    96. Williams MD, Roberts D, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol. 2007 Nov; 31(11):1645-52. PMID: 18059220.
      Citations: 51     Fields:    Translation:HumansCells
    97. Blumenschein GR, Kies MS, Papadimitrakopoulou VA, Lu C, Kumar AJ, Ricker JL, Chiao JH, Chen C, Frankel SR. Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs. 2008 Feb; 26(1):81-7. PMID: 17960324.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    98. Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007 Oct 20; 25(30):4800-5. PMID: 17947728.
      Citations: 63     Fields:    Translation:HumansCTClinical Trials
    99. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, S Wang X, Cleeland CS. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31. PMID: 17358040.
      Citations: 51     Fields:    Translation:Humans
    100. Kies MS. Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN). Curr Treat Options Oncol. 2007 Jun; 8(3):252-60. PMID: 17952388.
      Citations: 1     Fields:    Translation:Humans
    101. Curran D, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS, Jassem J, Baselga J, Rowinsky EK, Amellal N, Comte S, Bonner JA. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007 Jun 01; 25(16):2191-7. PMID: 17538164.
      Citations: 60     Fields:    Translation:HumansCTClinical Trials
    102. Kies MS. Induction chemotherapy for squamous cancer of the head and neck. Curr Oncol Rep. 2007 Mar; 9(2):129-33. PMID: 17288879.
      Citations:    Fields:    Translation:Humans
    103. Nash JW, Barrett TL, Kies M, Ross MI, Sneige N, Diwan AH, Lazar AJ. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications. J Cutan Pathol. 2007 Jan; 34(1):49-54. PMID: 17214855.
      Citations: 13     Fields:    Translation:Humans
    104. Williams MD, Chakravarti N, Kies MS, Maruya S, Myers JN, Haviland JC, Weber RS, Lotan R, El-Naggar AK. Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res. 2006 Dec 15; 12(24):7353-8. PMID: 17189407.
      Citations: 15     Fields:    Translation:HumansCells
    105. Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol. 2006 Sep 01; 24(25):4163-9. PMID: 16943532.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    106. Esmaeli B, Golio D, Kies M, DeMonte F. Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 2006 Sep-Oct; 22(5):366-70. PMID: 16985421.
      Citations: 7     Fields:    Translation:Humans
    107. Carducci MA, Musib L, Kies MS, Pili R, Truong M, Brahmer JR, Cole P, Sullivan R, Riddle J, Schmidt J, Enas N, Sinha V, Thornton DE, Herbst RS. Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer. J Clin Oncol. 2006 Sep 01; 24(25):4092-9. PMID: 16943527.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    108. Cohen EE, Haraf DJ, List MA, Kocherginsky M, Mittal BB, Rosen F, Brockstein B, Williams R, Witt ME, Stenson KM, Kies MS, Vokes EE. High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol. 2006 Jul 20; 24(21):3438-44. PMID: 16849759.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    109. Yom SS, Rosenthal DI, El-Naggar AK, Kies MS, Hessel AC. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jun; 101(6):761-8. PMID: 16731397.
      Citations: 6     Fields:    Translation:Humans
    110. Mrozek E, Kloos RT, Ringel MD, Kresty L, Snider P, Arbogast D, Kies M, Munden R, Busaidy N, Klein MJ, Sherman SI, Shah MH. Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2006 Jun; 91(6):2201-4. PMID: 16522694.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    111. Thomas SK, Fossella FV, Liu D, Schaerer R, Tsao AS, Kies MS, Pisters KM, Blumenschein GR, Glisson BS, Lee JJ, Herbst RS, Zinner RG. Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program. Clin Lung Cancer. 2006 Mar; 7(5):326-31. PMID: 16640804.
      Citations: 8     Fields:    Translation:Humans
    112. Gilbert J, Li Y, Pinto HA, Jennings T, Kies MS, Silverman P, Forastiere AA. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group. Head Neck. 2006 Mar; 28(3):197-204. PMID: 16470745.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    113. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 09; 354(6):567-78. PMID: 16467544.
      Citations: 1191     Fields:    Translation:HumansCTClinical Trials
    114. Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY. Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma. Clin Cancer Res. 2006 Jan 15; 12(2):653-61. PMID: 16428512.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    115. Weber RS, Kies MS, Rosenthal DI. Postoperative treatment intensification for improving outcome in the high-risk patient: an evolutionary process. Head Neck. 2005 Oct; 27(10):841-2. PMID: 16175566.
      Citations:    Fields:    Translation:Humans
    116. Sturgis EM, Moore BA, Glisson BS, Kies MS, Shin DM, Byers RM. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series. Head Neck. 2005 Sep; 27(9):748-56. PMID: 16086413.
      Citations: 7     Fields:    Translation:Humans
    117. Kim ES, Kies MS, Fossella FV, Glisson BS, Zaknoen S, Statkevich P, Munden RF, Summey C, Pisters KM, Papadimitrakopoulou V, Tighiouart M, Rogatko A, Khuri FR. Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma. Cancer. 2005 Aug 01; 104(3):561-9. PMID: 16028213.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    118. Rugo HS, Herbst RS, Liu G, Park JW, Kies MS, Steinfeldt HM, Pithavala YK, Reich SD, Freddo JL, Wilding G. Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results. J Clin Oncol. 2005 Aug 20; 23(24):5474-83. PMID: 16027439.
      Citations: 130     Fields:    Translation:HumansCTClinical Trials
    119. Herbst RS, Arquette M, Shin DM, Dicke K, Vokes EE, Azarnia N, Hong WK, Kies MS. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. J Clin Oncol. 2005 Aug 20; 23(24):5578-87. PMID: 16009949.
      Citations: 81     Fields:    Translation:HumansCTClinical Trials
    120. Maruya S, Kies MS, Williams M, Myers JN, Weber RS, Batsakis JG, El-Naggar AK. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol. 2005 Jul; 36(7):821-7. PMID: 16084953.
      Citations: 2     Fields:    Translation:Humans
    121. Papadimitrakopoulou V, Agelaki S, Tran HT, Kies M, Gagel R, Zinner R, Kim E, Ayers G, Wright J, Khuri F. Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors. Clin Cancer Res. 2005 Jun 01; 11(11):4151-9. PMID: 15930351.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    122. Vadlamudi RK, Balasenthil S, Sahin AA, Kies M, Weber RS, Kumar R, El-Naggar AK. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum Pathol. 2005 Jun; 36(6):670-5. PMID: 16021574.
      Citations: 20     Fields:    Translation:Humans
    123. Forastiere AA, Ang K, Brizel D, Brockstein BE, Dunphy F, Eisele DW, Goepfert H, Hicks WL, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A, Wheeler RH, Wolf GT, Worden F, Yueh B. Head and neck cancers. J Natl Compr Canc Netw. 2005 May; 3(3):316-91. PMID: 16002004.
      Citations: 12     Fields:    Translation:Humans
    124. Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clin Cancer Res. 2005 May 01; 11(9):3342-8. PMID: 15867233.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    125. Kies MS. New treatments in head and neck cancer. Clin Adv Hematol Oncol. 2005 Feb; 3(2):92-3. PMID: 16166973.
      Citations: 1     Fields:    Translation:Humans
    126. Rosenthal DI, Barker JL, El-Naggar AK, Glisson BS, Kies MS, Diaz EM, Clayman GL, Demonte F, Selek U, Morrison WH, Ang KK, Chao KS, Garden AS. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer. 2004 Dec 01; 101(11):2567-73. PMID: 15517582.
      Citations: 36     Fields:    Translation:Humans
    127. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004 Sep; 26(9):796-807. PMID: 15350026.
      Citations: 54     Fields:    Translation:Humans
    128. Kies MS. Head and neck cancer: integrating anti-EGFR treatment with standard therapy. J Natl Compr Canc Netw. 2004 Sep; 2 Suppl 2:S52-9. PMID: 19780246.
      Citations:    Fields:    Translation:Humans
    129. Maruya S, Kim HW, Weber RS, Lee JJ, Kies M, Luna MA, Batsakis JG, El-Naggar AK. Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance. J Mol Diagn. 2004 Aug; 6(3):180-90. PMID: 15269293.
      Citations: 10     Fields:    Translation:HumansCells
    130. Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Lung Cancer. 2004 Aug; 45(2):243-53. PMID: 15246197.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    131. Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, Mittal BB, Pelzer H, Fung BB, Witt ME, Wenig B, Portugal L, Weichselbaum RW, Vokes EE. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004 Aug; 15(8):1179-86. PMID: 15277256.
      Citations: 73     Fields:    Translation:Humans
    132. Khuri FR, Glisson BS, Kim ES, Statkevich P, Thall PF, Meyers ML, Herbst RS, Munden RF, Tendler C, Zhu Y, Bangert S, Thompson E, Lu C, Wang XM, Shin DM, Kies MS, Papadimitrakopoulou V, Fossella FV, Kirschmeier P, Bishop WR, Hong WK. Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors. Clin Cancer Res. 2004 May 01; 10(9):2968-76. PMID: 15131032.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    133. Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004 May; 26(5):447-55. PMID: 15122662.
      Citations: 22     Fields:    Translation:Humans
    134. Zinner RG, Glisson BS, Fossella FV, Pisters KM, Kies MS, Lee PM, Massarelli E, Sabloff B, Fritsche HA, Ro JY, Ordonez NG, Tran HT, Yang Y, Smith TL, Mass RD, Herbst RS. Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease. Lung Cancer. 2004 Apr; 44(1):99-110. PMID: 15013588.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    135. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1369-77. PMID: 15050312.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    136. Garden AS, Asper JA, Morrison WH, Schechter NR, Glisson BS, Kies MS, Myers JN, Ang KK. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer. 2004 Mar 15; 100(6):1171-8. PMID: 15022283.
      Citations: 21     Fields:    Translation:Humans
    137. Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen FR, Jovanovic B, Vokes EE. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res. 2004 Mar 15; 10(6):1956-62. PMID: 15041712.
      Citations: 44     Fields:    Translation:Humans
    138. Johnson FM, Garden A, Palmer JL, Kies M, Clayman G, Brumfield B, Khuri FR, Morrison W, Papadimitrakopoulou V, Diaz EM, Glisson BS. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. Cancer. 2004 Mar 01; 100(5):991-8. PMID: 14983495.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    139. Glisson B, Colevas AD, Haddad R, Krane J, El-Naggar A, Kies M, Costello R, Summey C, Arquette M, Langer C, Amrein PC, Posner M. HER2 expression in salivary gland carcinomas: dependence on histological subtype. Clin Cancer Res. 2004 Feb 01; 10(3):944-6. PMID: 14871971.
      Citations: 46     Fields:    Translation:HumansCTClinical Trials
    140. List MA, Rutherford JL, Stracks J, Pauloski BR, Logemann JA, Lundy D, Sullivan P, Goodwin W, Kies M, Vokes EE. Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients. Head Neck. 2004 Feb; 26(2):163-70. PMID: 14762885.
      Citations: 9     Fields:    Translation:Humans
    141. Kim ES, Vokes EE, Kies MS. Cetuximab in cancers of the lung and head & neck. Semin Oncol. 2004 Feb; 31(1 Suppl 1):61-7. PMID: 14981582.
      Citations: 2     Fields:    Translation:Humans
    142. Esmaeli B, Ahmadi MA, Youssef A, Diba R, Amato M, Myers JN, Kies M, El-Naggar A. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 2004 Jan; 20(1):22-6. PMID: 14752305.
      Citations: 26     Fields:    Translation:Humans
    143. Papadimitrakopoulou VA, Ginsberg LE, Garden AS, Kies MS, Glisson BS, Diaz EM, Clayman G, Morrison WH, Liu DD, Blumenschein G, Lippman SM, Schommer D, Gillenwater A, Goepfert H, Hong WK. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer. 2003 Nov 15; 98(10):2214-23. PMID: 14601092.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    144. Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, Haraf DJ, Vokes EE. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol. 2003 Aug; 14(8):1306-11. PMID: 12881397.
      Citations: 7     Fields:    Translation:Humans
    145. Herbst RS, Kies MS. Gefitinib: current and future status in cancer therapy. Clin Adv Hematol Oncol. 2003 Aug; 1(8):466-72. PMID: 16258434.
      Citations: 4     Fields:    Translation:HumansCells
    146. Rosen FR, Haraf DJ, Kies MS, Stenson K, Portugal L, List MA, Brockstein BE, Mittal BB, Rademaker AW, Witt ME, Pelzer H, Weichselbaum RR, Vokes EE. Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res. 2003 May; 9(5):1689-97. PMID: 12738722.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    147. Oh JL, Vokes EE, Kies MS, Mittal BB, Witt ME, Weichselbaum RR, Haraf DJ. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol. 2003 Apr; 14(4):564-9. PMID: 12649102.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    148. Masters GA, Hahn EA, Shevrin DH, Kies MS. Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):221-6. PMID: 12581577.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    149. Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol. 2003 Jan 15; 21(2):320-6. PMID: 12525525.
      Citations: 32     Fields:    Translation:Humans
    150. Argiris A, Haraf DJ, Kies MS, Vokes EE. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure. Oncologist. 2003; 8(4):350-60. PMID: 12897332.
      Citations: 11     Fields:    Translation:Humans
    151. Socinski MA, Schell MJ, Bakri K, Peterman A, Lee JH, Unger P, Yates S, Hudgens S, Kies MS. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer. 2002 Sep 15; 95(6):1265-73. PMID: 12216094.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    152. Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jul 15; 95(2):322-30. PMID: 12124833.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    153. Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G, Kies MS, Zinner R, Jung MS, Lu R, Lee JJ, Munden RF, Hong WK, Lee JS. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy. Cancer. 2002 Jul 15; 95(2):340-53. PMID: 12124835.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    154. Kies MS, Harari PM. Cetuximab (Imclone/Merck/Bristol-Myers Squibb). Curr Opin Investig Drugs. 2002 Jul; 3(7):1092-100. PMID: 12186273.
      Citations: 5     Fields:    Translation:HumansAnimals
    155. List MA, Lee Rutherford J, Stracks J, Haraf D, Kies MS, Vokes EE. An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck. Cancer. 2002 Jul 01; 95(1):98-104. PMID: 12115322.
      Citations: 11     Fields:    Translation:Humans
    156. Kim ES, Kies M, Herbst RS. Novel therapeutics for head and neck cancer. Curr Opin Oncol. 2002 May; 14(3):334-42. PMID: 11981281.
      Citations: 11     Fields:    Translation:Humans
    157. Socinski MA, Schell MJ, Peterman A, Bakri K, Yates S, Gitten R, Unger P, Lee J, Lee JH, Tynan M, Moore M, Kies MS. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol. 2002 Mar 01; 20(5):1335-43. PMID: 11870177.
      Citations: 71     Fields:    Translation:HumansCTClinical Trials
    158. Kuzel TM, Kies MS, Wu N, Hsieh YC, Rademaker AW. Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer. Cancer Invest. 2002; 20(5-6):634-43. PMID: 12197218.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    159. Herbst RS, Kies MS. ZD1839 (Iressa) in non-small cell lung cancer. Oncologist. 2002; 7 Suppl 4:9-15. PMID: 12202783.
      Citations: 8     Fields:    Translation:Humans
    160. Diaz EM, Kies MS. Chemotherapy for skull base cancers. Otolaryngol Clin North Am. 2001 Dec; 34(6):1079-85, viii. PMID: 11728933.
      Citations: 6     Fields:    Translation:Humans
    161. Herbst RS, Khuri FR, Fossella FV, Glisson BS, Kies MS, Pisters KM, Riddle JR, Terry KA, Lee JS. ZD1839 (Iressa) in non-small-cell lung cancer. Clin Lung Cancer. 2001 Aug; 3(1):27-32. PMID: 14656386.
      Citations:    Fields:    
    162. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001 May; 13(3):176-82. PMID: 11307061.
      Citations: 9     Fields:    Translation:Humans
    163. Kies MS, Haraf DJ, Rosen F, Stenson K, List M, Brockstein B, Chung T, Mittal BB, Pelzer H, Portugal L, Rademaker A, Weichselbaum R, Vokes EE. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001 Apr 01; 19(7):1961-9. PMID: 11283128.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    164. Mantz CA, Vokes EE, Stenson K, Kies MS, Mittal B, Witt ME, List MA, Weichselbaum RR, Haraf DJ. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. Cancer J. 2001 Mar-Apr; 7(2):140-8. PMID: 11324767.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    165. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA, Weichselbaum RR, Haraf DJ. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol. 2001 Mar; 12(3):343-7. PMID: 11332146.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    166. Kies MS, Bennett CL, Vokes EE. Locally advanced head and neck cancer. Curr Treat Options Oncol. 2001 Feb; 2(1):7-13. PMID: 12057136.
      Citations: 4     Fields:    Translation:Humans
    167. Mittal BB, Kepka A, Mahadevan A, Kies M, Pelzer H, List MA, Rademaker A, Logemann J. Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers. Int J Cancer. 2001; 96 Suppl:61-70. PMID: 11992387.
      Citations: 11     Fields:    Translation:Humans
    168. Haas NB, Manola J, Hudes G, Citrin DL, Kies MS, Davis TE. Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer. Am J Clin Oncol. 2000 Dec; 23(6):589-92. PMID: 11202803.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    169. Pfister DG, Ang K, Brockstein B, Colevas AD, Ellenhorn J, Goepfert H, Hicks WL, Hong WK, Kies MS, Lydiatt W, McCaffrey T, Mittal BB, Ridge JA, Schuller DE, Shah JP, Spencer S, Trotti A, Urba S, Weymuller EA, Wheeler RH, Wolf GT. NCCN Practice Guidelines for Head and Neck Cancers. Oncology (Williston Park). 2000 Nov; 14(11A):163-94. PMID: 11195409.
      Citations: 18     Fields:    Translation:Humans
    170. Vokes EE, Haraf DJ, Kies MS. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. Semin Oncol. 2000 Aug; 27(4 Suppl 8):34-8. PMID: 10952436.
      Citations: 7     Fields:    Translation:Humans
    171. Stenson KM, Haraf DJ, Pelzer H, Recant W, Kies MS, Weichselbaum RR, Vokes EE. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg. 2000 Aug; 126(8):950-6. PMID: 10922226.
      Citations: 23     Fields:    Translation:Humans
    172. Lingen MW, Chang KW, McMurray SJ, Solt DB, Kies MS, Mittal BB, Haines GK, Pelzer HJ. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000 Jul; 22(4):328-35. PMID: 10862014.
      Citations: 15     Fields:    Translation:Humans
    173. Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R, Dolan ME, Pelzer H, Sulzen L, Witt ME, Hsieh YC, Mittal BB, Weichselbaum RR. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000 Apr; 18(8):1652-61. PMID: 10764425.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    174. List MA, Stracks J, Colangelo L, Butler P, Ganzenko N, Lundy D, Sullivan P, Haraf D, Kies M, Goodwin W, Vokes EE. How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol. 2000 Feb; 18(4):877-84. PMID: 10673531.
      Citations: 27     Fields:    Translation:Humans
    175. List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, Vokes EE. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999 Mar; 17(3):1020-8. PMID: 10071297.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    176. Humerickhouse RA, Dolan ME, Haraf DJ, Brockstein B, Stenson K, Kies M, Sulzen L, Ratain MJ, Vokes EE. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. Clin Cancer Res. 1999 Feb; 5(2):291-8. PMID: 10037177.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    177. Haraf DJ, Kies M, Rademaker AW, Stenson K, Mittal B, Pelzer H, Wenig B, Witt ME, Sulzen L, Weichselbaum RR, Vokes EE. Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer. J Clin Oncol. 1999 Feb; 17(2):638-44. PMID: 10080609.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    178. NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network. Oncology (Williston Park). 1998 Nov; 12(11A):226-309. PMID: 10028513.
      Citations: 1     Fields:    Translation:Humans
    179. Kies MS, Haraf DJ, Athanasiadis I, Kozloff M, Mittal B, Pelzer H, Rademaker AW, Wenig B, Weichselbaum RR, Vokes EE. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol. 1998 Aug; 16(8):2715-21. PMID: 9704722.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    180. Tallman MS, Rademaker AW, Jahnke L, Brown SG, Bauman A, Mangan C, Kelly C, Rubin H, Kies MS, Shaw J, Kiel K, Gordon LI, Gradishar WJ, Winter JN. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer. Bone Marrow Transplant. 1997 Nov; 20(9):721-9. PMID: 9384473.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    181. Frank MW, Shields TW, Joob AW, Kies MS, Sturgis CD, Yeldandi A, Cribbins AJ, Fullerton DA. Lymphoepithelioma-like carcinoma of the lung. Ann Thorac Surg. 1997 Oct; 64(4):1162-4. PMID: 9354548.
      Citations: 2     Fields:    Translation:Humans
    182. Kies MS, Vokes EE. Does chemotherapy for head and neck cancer improve symptoms? Ann Oncol. 1997 May; 8(5):417-8. PMID: 9233517.
      Citations:    Fields:    Translation:Humans
    183. Athanasiadis I, Taylor S, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Cancer. 1997 Feb 01; 79(3):588-94. PMID: 9028372.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    184. Vokes EE, Mick R, Kies MS, Dolan ME, Malone D, Athanasiadis I, Haraf DJ, Kozloff M, Weichselbaum RR, Ratain MJ. Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. J Clin Oncol. 1996 May; 14(5):1663-71. PMID: 8622086.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    185. Athanasiadis I, Kies MS, Miller M, Ganzenko N, Joob A, Marymont M, Rademaker A, Gradishar WJ. Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer. Clin Cancer Res. 1995 Sep; 1(9):973-9. PMID: 9816069.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    186. Joob AW, Haines GK, Kies MS, Shields TW. Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1995 Jul; 60(1):217-22. PMID: 7598604.
      Citations: 22     Fields:    Translation:Humans
    187. Vokes EE, Kies M, Haraf DJ, Mick R, Moran WJ, Kozloff M, Mittal B, Pelzer H, Wenig B, Panje W, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol. 1995 Apr; 13(4):876-83. PMID: 7707114.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    188. Rosen F, Vokes EE, Lad T, Kies M, Wade J, Kilton LJ, Blough R, French S, Mullane M, Benson AB. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study. Invest New Drugs. 1995; 13(3):249-52. PMID: 8729954.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    189. Lyster MT, Kies MS, Kuzel TM. Neurologic complications of patients with small cell prostate carcinoma. Report of two cases. Cancer. 1994 Dec 15; 74(12):3159-63. PMID: 7982180.
      Citations: 1     Fields:    Translation:Humans
    190. Souhami RL, Brodin O, Duchesne G, Goldie J, Green M, Kies M, Mattson K, Mulshine J, Saijo N, Saunders M, et al. Second IASLC Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Biological basis of combined therapy. Lung Cancer. 1994 Mar; 10 Suppl 1:S3-5. PMID: 8087524.
      Citations:    Fields:    Translation:HumansCells
    191. Taylor SG, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol. 1994 Feb; 12(2):385-95. PMID: 8113846.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    192. Kies MS, Grinblatt D, Runge-Morris M, Blough R, Watkins A, Taylor S. Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck. Invest New Drugs. 1994; 12(1):45-7. PMID: 7960605.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    193. Arriagada R, Pignon JP, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al. Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients. Anticancer Res. 1994 Jan-Feb; 14(1B):333-5. PMID: 8166478.
      Citations: 5     Fields:    Translation:Humans
    194. Haines GK, Becker S, Ghadge G, Kies M, Pelzer H, Radosevich JA. Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. Arch Otolaryngol Head Neck Surg. 1993 Oct; 119(10):1142-7. PMID: 8104427.
      Citations: 6     Fields:    Translation:HumansCells
    195. Gordon L, Shapiro G, Rosen S, Kies M, Prachand S, Vriesendorp H. Separation of chronic lymphocytic-leukemia (cll) cells by a discontinuous density gradient - correlation with clinical stage. Int J Oncol. 1993 Jun; 2(6):981-4. PMID: 21573656.
      Citations:    Fields:    
    196. Haines GK, Ghadge GD, Becker S, Kies M, Pelzer H, Thimmappaya B, Radosevich JA. Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993; 63(5):289-95. PMID: 8100099.
      Citations: 4     Fields:    Translation:HumansCells
    197. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 03; 327(23):1618-24. PMID: 1331787.
      Citations: 201     Fields:    Translation:Humans
    198. Mittal BB, Pelzer H, Tsao CS, Ward WF, Johnson P, Friedman C, Sisson GA, Kies M. Intraoperative radiation of canine carotid artery, internal jugular vein, and vagus nerve. Therapeutic applications in the management of advanced head and neck cancers. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1425-30. PMID: 2248745.
      Citations:    Fields:    Translation:HumansAnimals
    199. Mittal BB, Sathiaseelan V, Kies MS. Simultaneous localized 915 MHz external and interstitial microwave hyperthermia to heat tumors greater than 3 cm in depth. Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):669-75. PMID: 2211214.
      Citations: 1     Fields:    Translation:Humans
    200. Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer. 1990 Feb 15; 65(4):885-9. PMID: 2297659.
      Citations: 20     Fields:    Translation:Humans
    201. Gradishar WJ, Vokes EE, Kies MS. Phase II trial of etoposide and doxorubicin in advanced head and neck cancer. Med Pediatr Oncol. 1990; 18(6):487-90. PMID: 2233521.
      Citations: 1     Fields:    Translation:Humans
    202. Taylor SG, Murthy AK, Caldarelli DD, Showel JL, Kiel K, Griem KL, Mittal BB, Kies M, Hutchinson JC, Holinger LD, et al. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol. 1989 Jul; 7(7):846-56. PMID: 2738622.
      Citations: 8     Fields:    Translation:Humans
    203. Runge-Morris MA, Kies MS, Vokes E, Blough R, Weidner L, Knop R, Rowland K. Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):269-73. PMID: 2793384.
      Citations: 2     Fields:    Translation:Humans
    204. Sternberger NH, Sternberger LA, Kies MW, Shear CR. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol. 1989 Feb; 21(2-3):241-8. PMID: 2783587.
      Citations: 11     Fields:    Translation:Animals
    205. Hamada T, Driscoll BF, Kies MW, Alvord EC. LPS augments adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Autoimmunity. 1989; 2(4):275-84. PMID: 2485079.
      Citations: 2     Fields:    Translation:AnimalsCells
    206. Kies MS, Gordon LI, Rosen ST, Kucuk O, Vriesendorp HM. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation. Exp Hematol. 1988 Mar; 16(3):190-4. PMID: 3276545.
      Citations:    Fields:    Translation:HumansCells
    207. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer. 1987 Nov 01; 60(9):2156-60. PMID: 3440225.
      Citations: 14     Fields:    Translation:Humans
    208. Goldman-Leikin RE, Herst CV, Kies MS, Variakojis D, Marder RJ, Rosen ST. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma in an atypical host. Arch Pathol Lab Med. 1987 Nov; 111(11):1054-6. PMID: 2889441.
      Citations:    Fields:    Translation:HumansCells
    209. Alvord EC, Jahnke U, Fischer EH, Kies MW, Driscoll BF, Compston DA. The multiple causes of multiple sclerosis: the importance of age of infections in childhood. J Child Neurol. 1987 Oct; 2(4):313-21. PMID: 2443550.
      Citations: 3     Fields:    Translation:Humans
    210. Kies MS, Mira JG, Crowley JJ, Chen TT, Pazdur R, Grozea PN, Rivkin SE, Coltman CA, Ward JH, Livingston RB. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study. J Clin Oncol. 1987 Apr; 5(4):592-600. PMID: 3031226.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    211. Elson PJ, Earhart RH, Kvols LK, Spiegel R, Keller AM, Kies MS, Davis TE, Stevens C, Gumas L, Trump DL. Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):331-2. PMID: 3815401.
      Citations: 3     Fields:    Translation:Humans
    212. Rosen ST, Gould VE, Salwen HR, Herst CV, Le Beau MM, Lee I, Bauer K, Marder RJ, Andersen R, Kies MS, et al. Establishment and characterization of a neuroendocrine skin carcinoma cell line. Lab Invest. 1987 Mar; 56(3):302-12. PMID: 3546933.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    213. Kira J, Bacon ML, Martenson RE, Deibler GE, Kies MW, Alvord EC. Experimental allergic encephalomyelitis in rabbits. A major encephalitogenic determinant within residues 1-44 of myelin basic protein. J Neuroimmunol. 1986 Sep; 12(3):183-93. PMID: 2426303.
      Citations:    Fields:    Translation:AnimalsCells
    214. Bourdette DN, Driscoll BF, Seil FJ, Kies MW, Alvord EC. Severity of demyelination in vivo correlates with serum myelination inhibition activity in guinea pigs having a new form of experimental allergic encephalomyelitis. Neurochem Pathol. 1986 Feb; 4(1):1-9. PMID: 2423931.
      Citations: 2     Fields:    Translation:AnimalsCells
    215. Driscoll BF, Kira J, Kies MW, Alvord EC. Mechanism of demyelination in the guinea pig. Separate sensitization with encephalitogenic myelin basic protein and nonencephalitogenic brain components. Neurochem Pathol. 1986 Feb; 4(1):11-22. PMID: 2423932.
      Citations: 3     Fields:    Translation:AnimalsCellsPHPublic Health
    216. Kies MS, Levitan N, Hong WK. Chemotherapy of head and neck cancer. Otolaryngol Clin North Am. 1985 Aug; 18(3):533-41. PMID: 4047673.
      Citations:    Fields:    Translation:Humans
    217. Citrin DL, Kies MS, Wallemark CB, Khandekar J, Kaplan E, Camacho F, Lind R. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60. PMID: 4005808.
      Citations: 2     Fields:    Translation:Humans
    218. Kies MS, Gordon LI, Hauck WW, Krespi Y, Ossoff RH, Pecaro BC, Yuska C, Lamut CH, Brand WN, Chang SK, et al. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer. Otolaryngol Head Neck Surg. 1985 Apr; 93(2):199-205. PMID: 2581211.
      Citations: 2     Fields:    Translation:Humans
    219. Driscoll BF, Kies MW, Alvord EC. The nature of the defect in experimental allergic encephalomyelitis (EAE)-resistant Lewis (Le-R) rats. J Immunol. 1985 Mar; 134(3):1567-70. PMID: 2578512.
      Citations: 1     Fields:    Translation:Animals
    220. Alvord EC, Driscoll BF, Kies MW. Large subpial plaques of demyelination in a new form of chronic experimental allergic encephalomyelitis in the guinea pig. Neurochem Pathol. 1985; 3(3):195-214. PMID: 2419809.
      Citations: 3     Fields:    Translation:AnimalsCells
    221. Kies MW. Species-specificity and localization of encephalitogenic sites in myelin basic protein. Springer Semin Immunopathol. 1985; 8(3):295-303. PMID: 2413562.
      Citations: 1     Fields:    Translation:AnimalsCells
    222. Gordon LI, Rosen ST, Vriesendorp HM, Kies MS, Kucuk O. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines. Cancer Res. 1984 Nov; 44(11):5404-8. PMID: 6091877.
      Citations: 1     Fields:    Translation:HumansCells
    223. Kies MS, Pecaro BC, Gordon LI, Hauck WW, Kraut MJ, Krespi Y, Ossoff RH, Schiff C, Shetty R, Sisson GA. Preoperative combination chemotherapy for advanced stage head and neck cancer. Promising early results. Am J Surg. 1984 Sep; 148(3):367-71. PMID: 6206742.
      Citations: 2     Fields:    Translation:Humans
    224. Cowan JD, Kies MS, Mulgrew PJ, Cerezo L. Addison's disease due to metastatic carcinoma. South Med J. 1984 Jun; 77(6):796-9. PMID: 6328677.
      Citations:    Fields:    Translation:Humans
    225. Schaeffer AJ, Grayhack JT, Merrill JM, Kies MS, Bulkley GJ, Shetty RM, Chmiel JS. Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary report. J Urol. 1984 Jun; 131(6):1073-6. PMID: 6726904.
      Citations: 1     Fields:    Translation:Humans
    226. Shields TW, Rosen ST, Hellerstein SM, Tsang T, Ujiki GT, Kies MS. Multimodality approach to treatment of carcinoma of the esophagus. Arch Surg. 1984 May; 119(5):558-62. PMID: 6538781.
      Citations: 7     Fields:    Translation:Humans
    227. Citrin DL, Elson P, Kies MS, Lind R. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications. Am J Med. 1984 May; 76(5):787-93. PMID: 6539069.
      Citations: 6     Fields:    Translation:Humans
    228. Kucuk O, Gordon LI, Kies MS, Spies S, Spies W, Vriesendorp HM. Estimation of hemopoietic potential by CFU-c and bone marrow scan in cancer patients. Exp Hematol. 1984 Feb; 12(2):101-6. PMID: 6321216.
      Citations:    Fields:    Translation:Humans
    229. Deibler GE, Boyd LF, Kies MW. Proteolytic activity associated with purified myelin basic protein. Prog Clin Biol Res. 1984; 146:249-56. PMID: 6201896.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    230. Rosen ST, Maciorowski Z, Wittlin F, Epstein AL, Gordon LI, Kies MS, Kucuk O, Kwaan HC, Vriesendorp H, Winter JN, et al. Estrogen receptor analysis in chronic lymphocytic leukemia. Blood. 1983 Nov; 62(5):996-9. PMID: 6626749.
      Citations: 2     Fields:    Translation:Humans
    231. Bockrath JM, Schaeffer AJ, Kies MS, Neiman HL. Ultrasound identification of impalpable testicle tumor. J Urol. 1983 Aug; 130(2):355-6. PMID: 6876291.
      Citations: 2     Fields:    Translation:Humans
    232. Iivanainen M, Driscoll B, Richert J, Leon M, Chu A, Kies M, Brown B, Wallen W, Madden D, Sever J. Oligoclonal IgG in the cerebrospinal fluid of guinea pigs with experimental allergic encephalomyelitis. . 1982 Dec; 171(3):272-5. PMID: 6184726.
      Citations:    
    233. Kies MS. Fluorouracil for colorectal cancer: a sobering look. JAMA. 1982 May 28; 247(20):2826. PMID: 7077790.
      Citations: 1     Fields:    Translation:Humans
    234. Driscoll BF, Kies MW, Alvord EC. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs. J Immunol. 1982 Feb; 128(2):635-8. PMID: 6172501.
      Citations: 1     Fields:    Translation:AnimalsCells
    235. Namikawa T, Richert JR, Driscoll BF, Kies MW, Alvord EC. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant. J Immunol. 1982 Feb; 128(2):932-4. PMID: 6172517.
      Citations: 1     Fields:    Translation:Animals
    236. Richert JR, Namikawa T, Kies MW, Alvord EC. Failure of serum from recovered rats to prevent enhanced adoptive transfer of experimental allergic encephalomyelitis. J Neurol Sci. 1982 Feb; 53(2):225-32. PMID: 6460091.
      Citations:    Fields:    Translation:AnimalsCells
    237. Sires LR, Hruby S, Alvord EC, Hellström I, Hellström KE, Kies MW, Martemspm R, Deibler GE, Beckman ED, Casnellie JE. Species restriction of a monoclonal antibody reacting with residues 130 to 137 in encephalitogenic myelin basic protein. Science. 1981 Oct 02; 214(4516):87-9. PMID: 6169147.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    238. Cowan JD, Kies MS. Detection of recurrent breast cancer. South Med J. 1981 Aug; 74(8):910-2. PMID: 6267718.
      Citations:    Fields:    Translation:Humans
    239. Richert JR, Kies MW, Alvord EC. Enhanced transfer of experimental allergic encephalomyelitis with Lewis rat lymph node cells. J Neuroimmunol. 1981 Jun; 1(2):195-203. PMID: 6175659.
      Citations: 3     Fields:    Translation:AnimalsCellsPHPublic Health
    240. Richert JR, Driscoll BF, Kies MW, Alvord EC. Experimental allergic encephalomyelitis: activation of myelin basic protein-sensitized spleen cells by specific antigen in culture. Cell Immunol. 1981 Mar 15; 59(1):42-53. PMID: 6163562.
      Citations: 2     Fields:    Translation:AnimalsCells
    241. Kies MS, Abbott OD, Rubin RN. Recurrence of hemolysis in hereditary spherocytosis: a case due to leukemic infiltration of an accessory spleen. Mil Med. 1981 Jan; 146(1):55-7. PMID: 6784002.
      Citations: 2     Fields:    Translation:Humans
    242. Cowan JD, Rubin RN, Kies MS, Cerezo L. Bone marrow necrosis. Cancer. 1980 Nov 15; 46(10):2168-71. PMID: 6893570.
      Citations: 4     Fields:    Translation:Humans
    243. Cowan JD, Kies MS, Roth JL, Joyce RP. Nerve conduction studies in patients treated with cis-diamminedichloroplatinum(II): a preliminary report. Cancer Treat Rep. 1980 Oct-Nov; 64(10-11):1119-22. PMID: 7193088.
      Citations: 8     Fields:    Translation:Humans
    244. Driscoll BF, Kies MW, Alvord EC. Enhanced transfer of experimental allergic encephalomyelitis with strain 13 guinea pig lymph node cells: requirement for culture with specific antigen and allogeneic peritoneal exudate cells. J Immunol. 1980 Oct; 125(4):1817-22. PMID: 6157746.
      Citations: 1     Fields:    Translation:AnimalsCells
    245. Kies MS, Posch JJ, Giolma JP, Rubin RN. Hemostatic function in cancer patients. Cancer. 1980 Aug 15; 46(4):831-7. PMID: 7397648.
      Citations: 4     Fields:    Translation:Humans
    246. Wymer DC, Kies MS. Adrenal simulation by renal uptake of 99mTc diphosphonate after radiotherapy. AJR Am J Roentgenol. 1980 Jun; 134(6):1256-8. PMID: 6770641.
      Citations:    Fields:    Translation:Humans
    247. Rubin RN, Kies MS, Posch JJ. Measurements of antithrombin III in solid tumor patients with and without hepatic metastases. Thromb Res. 1980 May 1-15; 18(3-4):353-60. PMID: 7414535.
      Citations: 2     Fields:    Translation:Humans
    248. Alvord EC, Shaw CM, Hruby S, Kies MW. Has myelin basic protein received a fair trial in the treatment of multiple sclerosis? Ann Neurol. 1979 Dec; 6(6):461-8. PMID: 93873.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    249. Driscoll BF, Kies MW, Alvord EC. Transfer of experimental allergic encephalomyelitis with guinea pig peritoneal exudate cells. Science. 1979 Feb 09; 203(4380):547-8. PMID: 83676.
      Citations: 1     Fields:    Translation:Animals
    250. Richert JR, Driscoll BF, Kies MW, Alvord EC. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J Immunol. 1979 Feb; 122(2):494-6. PMID: 84024.
      Citations: 16     Fields:    Translation:Animals
    251. Kies MS, Luedke DW, Boyd JF, McCue MJ. Neutropenic enterocolitis: two case reports of long-term survival following surgery. Cancer. 1979 Feb; 43(2):730-4. PMID: 283881.
      Citations: 14     Fields:    Translation:Humans
    252. Kies MS, Baker AW, Kennedy PS. Radionuclide scans in staging of carcinoma of the lung. Surg Gynecol Obstet. 1978 Aug; 147(2):175-6. PMID: 684566.
      Citations:    Fields:    Translation:Humans
    253. Kies MS, Kennedy PS. Central nervous system involvement in Ewing's sarcoma. Ann Intern Med. 1978 Aug; 89(2):226-7. PMID: 677591.
      Citations: 5     Fields:    Translation:Humans
    254. Sternberger NH, Itoyama Y, Kies MW, Webster HD. Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation. Proc Natl Acad Sci U S A. 1978 May; 75(5):2521-4. PMID: 353815.
      Citations: 47     Fields:    Translation:AnimalsCells
    255. Driscoll BF, Kies MW, Alvord EC. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential. J Immunol. 1976 Jul; 117(1):110-4. PMID: 58930.
      Citations: 4     Fields:    Translation:AnimalsPHPublic Health
    256. Griffith JA, Fabri PJ, Kies MS, Sinibaldi MR. [3 medical students confront death in a pediatric ward]. Sogo Kango. 1975 Aug; 10(3):74-80. PMID: 1041849.
      Citations:    Fields:    Translation:Humans
    257. Kies MW, Driscoll BF, Lisak RP, Alvord EC. Immunologic activity of myelin basic protein in strain 2 and strain 13 guinea pigs. J Immunol. 1975 Jul; 115(1):75-9. PMID: 50359.
      Citations: 2     Fields:    Translation:AnimalsCells
    258. Lisak RP, Zweiman B, Kies MW, Driscoll B. Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates. J Immunol. 1975 Feb; 114(2 Pt 1):546-9. PMID: 47353.
      Citations: 2     Fields:    Translation:AnimalsCells
    259. Seil FJ, Kies MW, Bacon M. Neural antigens and induction of myelination inhibition factor. J Immunol. 1975 Feb; 114(2 Pt 1):630-4. PMID: 47359.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    260. Driscoll BF, Kies MW, Alvord EC. Adoptive transfer of experimental allergic encephalomyelitis (EAE): prevention of successful transfer by treatment of donors with myelin basic protein. J Immunol. 1975 Jan; 114(1 Pt 2):291-2. PMID: 46879.
      Citations: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    261. Moore MJ, Behan PO, Kies MW, Matthews JM. Reaginic antibody in experimental allergic encephalomyelitis. I. Characterization of heat-labile skin-fixing antibody. Res Commun Chem Pathol Pharmacol. 1974 Sep; 9(1):119-32. PMID: 4140559.
      Citations:    Fields:    Translation:AnimalsCells
    262. Moore MJ, Matthews JM, Matthews TK, Behan PO, Kies MW. Reaginic antibody in experimental allergic encephalomyelitis. II. Histamine and serotonin blockade. Res Commun Chem Pathol Pharmacol. 1974 Sep; 9(1):133-44. PMID: 4140560.
      Citations:    Fields:    Translation:AnimalsCells
    263. Driscoll BF, Kies MW, Alvord EC. Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein. J Immunol. 1974 Jan; 112(1):392-7. PMID: 4130152.
      Citations: 9     Fields:    Translation:AnimalsCells
    264. Griffith JA, Fabri PJ, Kies MS, Sinibaldi MR. Three medical students confront death on a pediatric ward. A case report. J Am Acad Child Psychiatry. 1974; 13(1):72-7. PMID: 4855196.
      Citations:    Fields:    Translation:Humans
    265. Behan PO, Kies MW, Lisak RP, Sheremata W, Lamarche JB. Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates. Arch Neurol. 1973 Jul; 29(1):4-9. PMID: 4123120.
      Citations: 10     Fields:    Translation:AnimalsCells
    266. Kies MW, Driscoll BF, Seil FJ, Alvord EC. Myelination inhibition factor: dissociation from induction of experimental allergic encephalomyelitis. Science. 1973 Feb 16; 179(4074):689-90. PMID: 4119452.
      Citations: 5     Fields:    Translation:AnimalsCells
    267. Kies MW, Bump EA. A rapid qualitative test for detection of precipitating antibody to myelin basic protein. Res Commun Chem Pathol Pharmacol. 1972 Nov; 4(3):569-79. PMID: 4118128.
      Citations:    Fields:    Translation:AnimalsCells
    268. Levine S, Sowinski R, Gruenewald R, Kies MW. Experimental allergic encephalomyelitis. Production by myelin basic protein adsorbed on particulate adjuvants. Immunology. 1972 Oct; 23(4):609-14. PMID: 5084103.
      Citations: 1     Fields:    Translation:AnimalsCells
    269. Martenson RE, Deibler GE, Kies MW, Levine S, Alvord EC. Myelin basic proteins of mammalian and submammalian vertebrates: encephalitogenic activities in guinea pigs and rats. J Immunol. 1972 Aug; 109(2):262-70. PMID: 4114825.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    270. Behan PO, Behan WM, Feldman RG, Kies MW. Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases. Arch Neurol. 1972 Aug; 27(2):145-52. PMID: 4625188.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    271. Martenson RE, Deibler GE, Kies MW, McKneally SS, Shapira R, Kibler RF. Differences between the two myelin basic proteins of the rat central nervous system. A deletion in the smaller protein. Biochim Biophys Acta. 1972 Mar 15; 263(1):193-203. PMID: 5013289.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    272. Levine S, Sowinski R, Kies MW. Treatment of experimental allergic encephalomyelitis with encephalitogenic basic proteins. . 1972 Feb; 139(2):506-10. PMID: 4621748.
      Citations:    
    273. Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem. 1972; 2(2):139-65. PMID: 4623901.
      Citations: 141     Fields:    Translation:HumansAnimalsCells
    274. Kies MW, Martenson RE, Deibler GE. Myelin basic proteins. Adv Exp Med Biol. 1972; 32(0):201-14. PMID: 4137071.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    275. Martenson RE, Deibler GE, Kies MW. Electrophoretic characterization of basic proteins in acid extracts of central nervous system tissue. J Neurochem. 1971 Dec; 18(12):2417-26. PMID: 4109320.
      Citations: 6     Fields:    Translation:AnimalsCells
    276. Martenson RE, Deibler GE, Kies MW. The occurrence of two myelin basic proteins in the central nervous system of rodents in the suborders Myomorpha and Sciuromorpha. J Neurochem. 1971 Dec; 18(12):2427-33. PMID: 5135903.
      Citations: 8     Fields:    Translation:AnimalsCells
    277. Rocklin RE, Sheremata WA, Feldman RG, Kies MW, David JR. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med. 1971 Apr 15; 284(15):803-8. PMID: 4323673.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    278. Martenson RE, Deibler GE, Kies MW. Microheterogeneity and species-related differences among myelin basic proteins. Res Publ Assoc Res Nerv Ment Dis. 1971; 49:76-94. PMID: 5133706.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    279. Chaparas SD, Clark RG, Kies MW, Hedrick SR. Transformation of lymphocytes from monkeys with experimental allergic encephalomyelitis. Res Commun Chem Pathol Pharmacol. 1970 Sep; 1(5):637-52. PMID: 5002788.
      Citations: 1     Fields:    Translation:AnimalsCells
    280. Lisak RP, Falk GA, Heinze RG, Kies MW, Alvord EC. Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein. J Immunol. 1970 Jun; 104(6):1435-46. PMID: 4986769.
      Citations: 8     Fields:    Translation:AnimalsCellsPHPublic Health
    281. Levine S, Hoenig EM, Kies MW. Allergic encephalomyelitis: immunologically specific inhibition of cellular passive transfer by encephalitogenic basic proteins. Clin Exp Immunol. 1970 Apr; 6(4):503-17. PMID: 4991116.
      Citations: 9     Fields:    Translation:HumansAnimalsPHPublic Health
    282. Deibler GE, Martenson RE, Kies MW. Gel filtration of proteins at acid pH. Application to molecular weight estimation of myelin basic proteins. Biochim Biophys Acta. 1970 Feb 17; 200(2):342-52. PMID: 5416125.
      Citations: 3     Fields:    Translation:HumansAnimals
    283. Martenson RE, Deibler GE, Kies MW. Myelin basic proteins of the rat central nervous system. Purification, encephalitogenic properties, and amino acid compositions. Biochim Biophys Acta. 1970 Feb 17; 200(2):353-62. PMID: 5416126.
      Citations: 13     Fields:    Translation:Animals
    284. Lisak RP, Heinze RG, Kies MW. Relationships between antibodies and experimental allergic encephalomyelitis. 3. Coprecipitation and radioautography of 125I-labeled antigen-antibody complexes for detection of antibodies to myelin basic protein. Int Arch Allergy Appl Immunol. 1970; 37(6):621-9. PMID: 4983347.
      Citations: 3     Fields:    Translation:AnimalsCells
    285. Alvord EC, Shaw CM, Lisak RP, Falk GA, Kies MW. Relationships between antibodies and experimental allergic encephalomyelitis. V. Antibodies and delayed hypersensitivity in production and prevention of experimental allergic encephalomyelitis. Int Arch Allergy Appl Immunol. 1970; 38(4):403-12. PMID: 4984466.
      Citations: 3     Fields:    Translation:AnimalsCells
    286. Hruby S, Shaw CM, Alvord EC, August CS, Kies MW. Relationships between antibodies and experimental allergic encephalomyelitis. II. Identification and separation of species-specific non-encephalitogenic contaminants of encephalitogenic basic proteins. Int Arch Allergy Appl Immunol. 1970; 37(5):532-45. PMID: 5410778.
      Citations: 1     Fields:    Translation:AnimalsCells
    287. Vogel CL, De Vita VT, Lisak RP, Kies MW. Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative. Cancer Res. 1969 Dec; 29(12):2249-53. PMID: 5369677.
      Citations: 1     Fields:    Translation:Animals
    288. Falk GA, Kies MW, Alvord EC. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression. J Immunol. 1969 Dec; 103(6):1248-53. PMID: 5361563.
      Citations: 7     Fields:    Translation:Animals
    289. Martenson RE, Deibler GE, Kies MW. Microheterogeneity of guinea pig myelin basic protein. J Biol Chem. 1969 Aug 25; 244(16):4261-7. PMID: 5806574.
      Citations: 10     Fields:    Translation:AnimalsCells
    290. Martenson RE, Deibler GE, Kies MW. Extraction of rat myelin basic protein free of other basic proteins of whole central nervous system tissue. An analysis of its electrophoretic heterogeneity. J Biol Chem. 1969 Aug 25; 244(16):4268-72. PMID: 5806575.
      Citations: 8     Fields:    Translation:AnimalsCells
    291. Lisak RP, Heinze RG, Kies MW, Alvord EC. Antibodies to encephalitogenic basic protein in experimental allergic encephalomyelitis. . 1969 Mar; 130(3):814-8. PMID: 4975295.
      Citations:    
    292. Borriss E, August CS, Kies MW. In vitro effect of brain antigens on C-14-leucine incorporation in sensitized lymphoid cells. Int Arch Allergy Appl Immunol. 1969; 36:Suppl:218-23. PMID: 5309132.
      Citations:    Fields:    Translation:Animals
    293. Alvord EC, Hruby S, Hughes K, Shaw CM, Kies MW. Comparisons of organ-specific antigens of the central nervous system. Int Arch Allergy Appl Immunol. 1969; 36:Suppl:276-92. PMID: 5373030.
      Citations: 1     Fields:    Translation:Animals
    294. Kies MW, Alvord EC. Multiplicity of encephalitogenic myelin basic proteins. I. Relative molecular sizes related to methods of preparation. Int Arch Allergy Appl Immunol. 1969; 36:Suppl:182-202. PMID: 5373025.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    295. Alvord EC, Hruby S, Shaw CM, Kies MW. Multiplicity of encephalitogenic myelin basic proteins. II. Antigenic determinants related to species of origin and molecular size. Int Arch Allergy Appl Immunol. 1969; 36:Suppl:203-17. PMID: 4984656.
      Citations: 1     Fields:    Translation:HumansAnimals
    296. Seil FJ, Falk GA, Kies MW, Alvord EC. The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. Exp Neurol. 1968 Dec; 22(4):545-55. PMID: 4179459.
      Citations: 19     Fields:    Translation:AnimalsCells
    297. Behan PO, Geschwind N, Lamarche JB, Lisak RP, Kies MW. Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet. 1968 Nov 09; 2(7576):1009-12. PMID: 4176341.
      Citations: 11     Fields:    Translation:HumansCells
    298. Falk GA, Kies MW, Alvord EC. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis. J Immunol. 1968 Oct; 101(4):638-44. PMID: 4971475.
      Citations: 1     Fields:    Translation:AnimalsCells
    299. Lisak RP, Kies MW. Mycobacterial suppression of delayed hypersensitivity in experimental allergic encephalomyelitis. . 1968 May; 128(1):214-8. PMID: 4968539.
      Citations:    
    300. Falk GA, Heinze RG, Kies MW, Alvord EC. Skin-fixing antibody in experimental allergic encephalomyelitis. J Immunol. 1968 Feb; 100(2):321-8. PMID: 5639700.
      Citations: 3     Fields:    Translation:AnimalsCells
    301. Lisak RP, Heinze RG, Falk GA, Kies MW. Search for anti-encephalitogen antibody in human demyelinative diseases. Neurology. 1968 Jan; 18(1 Pt 2):122-8. PMID: 5299949.
      Citations: 5     Fields:    Translation:HumansCells
    302. Livine S, Hoenig EM, Kies MW. Allergic encephalomyelitis. Passive transfer prevented by encephalitogen. Science. 1967 Sep 13; 161(3846):1155-7. PMID: 5597309.
      Citations:    Fields:    Translation:Animals
    303. August CS, Kies MW. Delayed-type skin sensitivity to human encephalitogen in experimental allergic encephalomyelitis. Nature. 1967 Jun 03; 214(5092):1021-2. PMID: 6055397.
      Citations: 1     Fields:    Translation:HumansAnimals
    304. Lampert PW, Kies MW. Mechanism of demyelination in allergic encephalomyelitis of guinea pigs. An electron microscopic study. Exp Neurol. 1967 Jun; 18(2):210-23. PMID: 6026608.
      Citations: 13     Fields:    Translation:AnimalsCells
    305. August CS, Bier C, Kies MW, Alvord EC. Radioimmunoassay for antibodies in experimental allergic encephalomyelitis (EAE). J Neuropathol Exp Neurol. 1967 Jan; 26(1):158. PMID: 6022147.
      Citations:    Fields:    Translation:Cells
    306. Kies MW, Alvord EC, Martenson RE, Lebaron FN. Encephalitogenic activity of bovine basic proteins. Science. 1966 Feb 18; 151(3712):821-2. PMID: 17746725.
      Citations: 2     Fields:    
    307. LEVINE S, WENK EJ, KIES MW, ALVORD EC. CENTRAL NERVOUS SYSTEM TISSUE: IS IT AN IMMUNOLOGIC ADJUVANT? Neurology. 1965 Jun; 15:560-4. PMID: 14312779.
      Citations: 2     Fields:    Translation:Animals
    308. KIES MW. PANEL DISCUSSION ON SPECIES VARIABILITY AND MULTIPLE ANTIGENS IN EAE: SUMMARY STATEMENT. Ann N Y Acad Sci. 1965 Mar 31; 122:242-4. PMID: 14313481.
      Citations: 1     Fields:    
    309. ALVORD EC, SHAW CM, HRUBY S, KIES MW. ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY. Ann N Y Acad Sci. 1965 Mar 31; 122:333-45. PMID: 14313493.
      Citations: 19     Fields:    Translation:Animals
    310. THOMPSON EB, KIES MW. CURRENT STUDIES ON THE LIPIDS AND PROTEINS OF MYELIN. Ann N Y Acad Sci. 1965 Mar 31; 122:129-47. PMID: 14313474.
      Citations: 5     Fields:    Translation:Cells
    311. KIES MW, THOMPSON EB, ALVORD EC. THE RELATIONSHIP OF MYELIN PROTEINS TO EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. Ann N Y Acad Sci. 1965 Mar 31; 122:148-60. PMID: 14313475.
      Citations: 18     Fields:    Translation:AnimalsCells
    312. SHAW CM, ALVORD EC, KAKU J, KIES MW. CORRELATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH DELAYED-TYPE SKIN SENSITIVITY TO SPECIFIC HOMOLOGOUS ENCEPHALITOGEN. Ann N Y Acad Sci. 1965 Mar 31; 122:318-31. PMID: 14313491.
      Citations: 20     Fields:    Translation:Animals
    313. Kies MW, Alvord EC. Demyelinating Diseases. Science. 1964 Apr 17; 144(3616):320-1. PMID: 17752573.
      Citations:    Fields:    
    314. MUELLER P, KIES MW, ALVORD EC, YAMAMOTO RS. EFFECT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS ON GUINEA PIG PLASMA LIPID FRACTIONS. . 1964 Apr; 115:1095-9. PMID: 14166568.
      Citations:    
    315. KIES MW, MUELLER S, ALVORD EC. INFLUENCE OF ASCORBIC ACID DEFICIENCY ON IMMUNOLOGIC MECHANISMS. Z Immunitats Allergieforsch. 1964 Mar; 126:228-33. PMID: 14185400.
      Citations:    
    316. KIES MW, LAATSCH RH, ALVORD EC, SILVA OL. CHEMICAL AND IMMUNOLOGICAL STUDIES ON MYELIN FROM GUINEA PIG BRAIN. Z Immunitats Allergieforsch. 1964 Mar; 126:25-32. PMID: 14185402.
      Citations:    
    317. ALVORD EC, SHAW CM, FAHLBERG WJ, KIES MW. AN ANALYSIS OF COMPONENTS OF FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. Z Immunitats Allergieforsch. 1964 Mar; 126:193-208. PMID: 14185397.
      Citations:    
    318. ALVORD EC, SHAW CM, FAHLBERG WJ, KIES MW. AN ANALYSIS OF VARIOUS TYPES OF INHIBITION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. Z Immunitats Allergieforsch. 1964 Mar; 126:217-27. PMID: 14185399.
      Citations:    
    319. SHAW CM, ALVORD EC, FAHLBERG WJ, KIES MW. SUBSTITUTES FOR THE MYCOBACTERIA IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. J Immunol. 1964 Jan; 92:28-40. PMID: 14139543.
      Citations: 12     Fields:    Translation:AnimalsCells
    320. SHAW CM, ALVORD EC, KIES MW. STRAIGHT CHAIN HYDROCARBONS AS SUBSTITUTES FOR THE OIL IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. J Immunol. 1964 Jan; 92:24-7. PMID: 14139542.
      Citations: 4     Fields:    Translation:AnimalsCells
    321. SNYDER SH, MYRON P, KIES MW, BERLOW S. Metabolism of 2-C14 labeled L-histidine in histidinemia. J Clin Endocrinol Metab. 1963 Jun; 23:595-7. PMID: 13989745.
      Citations: 1     Fields:    Translation:Humans
    322. SHAW CM, ALVORD EC, FAHLBERG WJ, KIES MW. Specificity of encephalitogen-induced inhibition of experimental "allergic" encephalomyelitis in the guinea pig. J Immunol. 1962 Jul; 89:54-61. PMID: 13911448.
      Citations: 4     Fields:    Translation:Animals
    323. LAATSCH RH, KIES MW, GORDON S, ALVORD EC. The encephalomyelitic activity of myelin isolated by ultracentrifugation. J Exp Med. 1962 Apr 01; 115:777-88. PMID: 14461228.
      Citations: 27     Fields:    Translation:AnimalsCells
    324. MUELLER PS, KIES MW, ALVORD EC, SHAW CM. Prevention of experimental allergic encephalomyelitis (EAE) by vitamin C deprivation. J Exp Med. 1962 Feb 01; 115:329-38. PMID: 14476938.
      Citations: 2     Fields:    Translation:Animals
    325. SHAW CM, ALVORD EC, FAHLBERG WJ, KIES MW. Adjuvant-antigen relationships in the production of experimental "allergic" encephalomyelitis in the guinea pig. J Exp Med. 1962 Jan 01; 115:169-79. PMID: 13911447.
      Citations: 9     Fields:    Translation:AnimalsCells
    326. KIES MW, SHAW CM, FAHLBERG WJ, ALVORD EC. Factors affecting the suppression of allergic encephalomvelitis by homologous brain protein fractions. Ann Allergy. 1960 Aug; 18:849-58. PMID: 14409004.
      Citations: 1     Fields:    Translation:Humans
    327. SHAW CM, FAHLBERG WJ, KIES MW, ALVORD EC. Suppression of experimental "allergic" encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain. J Exp Med. 1960 Feb 01; 111:171-80. PMID: 13831267.
      Citations: 8     Fields:    Translation:Animals
    328. ALVORD EC, KIES MW. Clinico-pathologic correlations in experimental allergic encephalomyelitis. II. Development of an index for quantitative assay of encephalitogenic activity of antigens. J Neuropathol Exp Neurol. 1959 Jul; 18(3):447-57. PMID: 13665388.
      Citations: 15     Fields:    Translation:Animals
    329. ALVORD EC, MAGEE KR, KIES MW, GOLDSTEIN NP. Clinico-pathologic correlations in experimental allergic encephalomyelitis. I. Observations on the early lesion. J Neuropathol Exp Neurol. 1959 Jul; 18(3):442-6. PMID: 13665387.
      Citations: 6     Fields:    Translation:Animals
    330. KIES MW, ALVORD EC. [Prevention of allergic encephalomyelitis by prior injection of adjuvants]. Nature. 1958 Oct 18; 182(4642):1106. PMID: 13590248.
      Citations: 14     Fields:    Translation:Animals
    331. KIES MW, ALVORD EC, ROBOZ E. Production of experimental allergic encephalomyelitis in guinea pigs with fractions isolated from bovine spinal cord and killed tubercle bacilli. Nature. 1958 Jul 12; 182(4628):104-5. PMID: 13566196.
      Citations: 2     Fields:    Translation:AnimalsCells
    332. KIES MW, ALVORD EC, ROBOZ E. The allergic encephalomyelitic activity of a collagen-like compound from bovine spinal cord. II. J Neurochem. 1958; 2(2-3):261-4. PMID: 13576155.
      Citations: 2     Fields:    Translation:Animals
    333. KIES MW, GOLDSTEIN NP, MURPHY JB, ROBOZ E, ALVORD EC. Occurrence of lipemia in experimental allergic encephalomvelitis. Neurology. 1957 Mar; 7(3):175-88. PMID: 13407851.
      Citations: 4     Fields:    Translation:Humans
    334. Corrigendum. Bone Marrow Transplantation. 21:861.
    335. Separation of chronic lymphocytic leukemia (CLL) cells by a discontinuous density gradient. International Journal of Oncology. 2:981-984.
    336. Depression and oropharynx cancer outcome. Psychosomatic Medicine. 78:38-48.
    337. Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer. Frontiers in Oncology. 1.
    338. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope.
    339. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma. Head and Neck.
    340. Merkel cell carcinoma of the head and neck. Head and Neck. 38:E452-E458.
    341. Reirradiation of head and neck cancers with intensity modulated radiation therapy. International Journal of Radiation Oncology Biology Physics. 95:1117-1131.
    342. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer. 122:3411-3412.
    343. Head and neck cancer symposium. Current Opinion in Oncology. 14:308-309.
    344. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. International Journal of Cancer. 138:1290-1297.
    345. Laryngeal squamous cell carcinoma. 691-721.
    346. Evolutionary action score of TP53 identifies high-risk mutations associated with decreased survival and increased distant metastases in head and neck cancer. Cancer Research. 75:1527-1536.
    347. Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients. Cancer Research. 75:1205-1215.
    348. Radiotherapy and Oncology. 120:48-55.
    349. Examination of the larynx and pharynx. New England Journal of Medicine. 358.
    350. Reduced acute toxicity and improved efficacy from intensitymodulated proton therapy (IMPT) for the management of head and neck cancer. Chinese Clinical Oncology. 5.
    351. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head and Neck.
    352. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clinical Cancer Research. 22:725-733.
    353. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer.
    354. Biological basis of combined therapy. Lung Cancer. 10.
    355. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head and Neck. 37:644-649.
    356. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas. Head and Neck.
    357. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Annals of Oncology. 27:318-323.
    358. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology Biology Physics.
    359. Advanced head and neck malignancy. 723-754.
    360. Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus. Oncotarget. 7:23227-23238.
    KIES's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (955)
    Explore
    _
    Co-Authors (138)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _